William Desmarais
Nessuna posizione attualmente
Profilo
William Desmarais served as Vice President-Business Development at Momenta Pharmaceuticals, Inc. from 2017 to 2021.
He then worked as Chief Business Officer at TScan Therapeutics, Inc. from 2021 to 2023.
Desmarais holds an MBA from Massachusetts Institute of Technology, a doctorate from Brandeis University, and an undergraduate degree from Purdue University.
Precedenti posizioni note di William Desmarais
| Società | Posizione | Fine |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2021 |
Formazione di William Desmarais
| Brandeis University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Purdue University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- William Desmarais
